Diabetes and cancer risk: A Mendelian randomization study

被引:58
|
作者
Goto, Atsushi [1 ]
Yamaji, Taiki [1 ]
Sawada, Norie [1 ]
Momozawa, Yukihide [2 ]
Kamatani, Yoichiro [2 ]
Kubo, Michiaki [3 ]
Shimazu, Taichi [1 ]
Inoue, Manami [1 ]
Noda, Mitsuhiko [4 ]
Tsugane, Shoichiro [1 ]
Iwasaki, Motoki [1 ]
机构
[1] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan
[2] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan
[3] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[4] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan
基金
日本学术振兴会;
关键词
diabetes; Mendelian randomization; genetics; epidemiology; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; JAPANESE; VARIANTS; METAANALYSIS; MELLITUS; JPHC;
D O I
10.1002/ijc.32310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Earlier cohort studies using conventional regression models have consistently shown an increased cancer risk among individuals with type 2 diabetes. However, reverse causality and residual confounding due to common risk factors could exist, and it remains unclear whether diabetes per se contributes to cancer development. Mendelian randomization analyses might clarify the true association between diabetes and cancer risk. We conducted a case-cohort study with 10,536 subcohort subjects and 3,541 newly diagnosed cancer cases derived from 32,949 eligible participants aged 40-69 years within the Japan Public Health Center-based Prospective Study. With 29 known type 2 diabetes susceptibility variants, we used an inverse variance-weighted method to estimate hazard ratios for the associations of diabetes with risks of total and site-specific cancers. The hazard ratios of cancer per doubling of the probability of diabetes were 1.03 (95% confidence interval [CI], 0.92-1.15) overall, 1.08 (95% CI: 0.73-1.59) for the pancreas, 0.80 (95% CI: 0.57-1.14) for the liver and 0.90 (95% CI: 0.74-1.10) for the colorectum. Additional analyses, using publicly available large-scale genome-wide association study data on colorectal cancer in Japan, resulted in a narrower CI (hazard ratio: 1.00; 95% CI: 0.93-1.07). In this prospective Mendelian randomization study with a large number of incident cancer cases, we found no strong evidence to support associations between diabetes and overall and site-specific cancer risks. Our findings suggest that there is little evidence to support the genetic role of type 2 diabetes in cancer development in the Japanese population.
引用
收藏
页码:712 / 719
页数:8
相关论文
共 50 条
  • [41] Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes: A Mendelian Randomization Study
    Zwakenberg, Sabine R.
    Remmelzwaal, Sharon
    Beulens, Joline W. J.
    Booth, Sarah L.
    Burgess, Stephen
    Dashti, Hassan S.
    Imamura, Fumiaki
    Feskens, Edith J. M.
    van der Schouw, Yvonne T.
    Sluijs, Ivonne
    [J]. DIABETES, 2019, 68 (01) : 220 - 225
  • [42] Smoking and coronary artery disease risk in patients with diabetes: A Mendelian randomization study
    Chen, Songzan
    Yang, Fangkun
    Xu, Tian
    Wang, Yao
    Zhang, Kaijie
    Fu, Guosheng
    Zhang, Wenbin
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Type 2 diabetes mellitus and the risk of male infertility: a Mendelian randomization study
    Zhu, Xiao-Bin
    Niu, Zhi-Hong
    Fan, Wei-Min
    Sheng, Chang-Sheng
    Chen, Qian
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [44] Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study
    Manousaki, Despoina
    Harroud, Adil
    Mitchell, Ruth E.
    Ross, Stephanie
    Forgetta, Vince
    Timpson, Nicholas J.
    Smith, George Davey
    Polychronakos, Constantin
    Richards, J. Brent
    [J]. PLOS MEDICINE, 2021, 18 (02)
  • [45] A Mendelian Randomization Study on Infant Length and Type 2 Diabetes Mellitus Risk
    Zhuang, He
    Zhang, Ying
    Yang, Shuo
    Cheng, Liang
    Liu, Shu-Lin
    [J]. CURRENT GENE THERAPY, 2019, 19 (04) : 224 - 231
  • [46] Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study
    Aikens, Rachael C.
    Zhao, Wei
    Saleheen, Danish
    Reilly, Muredach P.
    Epstein, Stephen E.
    Tikkanen, Emmi
    Salomaa, Veikko
    Voight, Benjamin F.
    [J]. DIABETES, 2017, 66 (02) : 543 - 550
  • [47] RISK OF FRAGILITY FRACTURES IN INDIVIDUALS WITH DIABETES. AN OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDY
    Emanuelsson, F. K.
    Afzal, S.
    Nordestgaard, B. G.
    Benn, M.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E40 - E40
  • [48] The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian randomization study
    Fang, Ting
    Deng, Xiaoqing
    Wang, Jingyi
    Han, Fei
    Liu, Xiangyang
    Liu, Yajin
    Sun, Bei
    Chen, Liming
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] Risk cycling in diabetes and autism spectrum disorder: a bidirectional Mendelian randomization study
    Yu, Yunfeng
    Yang, Xinyu
    Hu, Gang
    Tong, Keke
    Wu, Jingyi
    Yu, Rong
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [50] Type 2 diabetes mellitus and the risk of abnormal spermatozoa: A Mendelian randomization study
    Dai, Mengyuan
    Guo, Weijie
    Zhu, San
    Gong, Guidong
    Chen, Mei
    Zhong, Zhuoling
    Guo, Junling
    Zhang, Yaoyao
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13